An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology
Die Pharmazie · 01.05.2024 · 79 (3-5)
DOI: 10.31083/ph.2024.3647 ↗Kurz gefasst
Fachartikel in der Zeitschrift Die Pharmazie, online erschienen am 01.05.2024. Verfasst von Runze Jin und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Hyperuricemia (HUA) is a disorder of uric acid metabolism, which can lead to the formation of gouty arthritis, kidney inflammation and other damages. Previous studies have found that the alcohol extract of Poria cutis can reduce the level of uric acid and protect against kidney injury. Based on network pharmacology, the core targets and main active components of P. cutis intervention in HUA were determined. Most of the potential active ingredients are triterpenoid acids such as tumulosic acid (TA) and eburicoic acid (EA), and the potential targets are TNF and IL-6, which are associated with inflammation. In vitro experiments have shown that TA can significantly inhibit the release of NO, TNF-α and IL-6 in inflammatory RAW264.7 cell culture medium and the expression of TNF-α and IL-6 in RAW264.7 cells. This study suggests that TA based on network pharmacological screening has obvious anti-inflammatory effect on inflammatory RAW264.7 cells and is a promising anti-inflammatory compound.
Zitieren
APA
Jin, R., Zhao, Z., Zhang, Q., Sun, Y., Wang, W., Peng, D., Nian, S., & Zhou, L. (2024). An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology. Die Pharmazie, 79(3-5). https://doi.org/10.31083/ph.2024.3647
Vancouver
Jin R, Zhao Z, Zhang Q, Sun Y, Wang W, Peng D, et al. An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology. Die Pharmazie. 2024;79(3-5). doi:10.31083/ph.2024.3647
BibTeX
@article{Jin2024,
author = {Jin, Runze and Zhao, Zitong and Zhang, Qing and Sun, YU and Wang, Wei and Peng, Daiyin and Nian, Sihui and Zhou, Lingyun},
title = {An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology},
journal = {Die Pharmazie},
year = {2024},
volume = {79},
number = {3-5},
doi = {10.31083/ph.2024.3647}
}
EUVIMED